Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy

Gynecologic Oncology

Volumn 124, Issue 3, 2012, Pages 542-548

  Penner, Kristine R ^a,b,c   Dorigo, Oliver ^b   Aoyama, Chisa ^a   Ostrzega, Nora ^a   Balzer, Bonnie L ^c   Rao, Jianyu ^b   Walsh, Christine S ^c   Cass, Ilana ^c   Holschneider, Christine H ^a  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Endometrial cancer; Predictors of resolution; Premenopausal; Progestin therapy

Indexed keywords

GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NORETHISTERONE; PROGESTERONE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPLEX ATYPICAL HYPERPLASIA; DECIDUALIZATION; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; OUTCOME ASSESSMENT; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; COHORT STUDIES; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; PRECANCEROUS CONDITIONS; PREMENOPAUSE; PROGESTINS; RETROSPECTIVE STUDIES;

EID: 84856733328     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.11.004     Document Type: Article

References (38)

1. American Cancer Society Cancer Facts & Figures 2010 2010 American Cancer Society Atlanta
2. S.D. Reed, K.M. Newton, W.L. Clinton, M. Epplein, R. Garcia, and K. Allison Incidence of endometrial hyperplasia Am J Obstet Gynecol 200 2009 678 e1-6
3. D.G. Gallup, and R.J. Stock Adenocarcinoma of the endometrium in women 40 years of age or younger Obstet Gynecol 64 1984 417 420
4. J.V. Bokhman, O.F. Chepick, A.T. Volkova, and A.S. Vishnevsky Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol 20 1985 139 155
5. L.R. Duska, A. Garrett, B.R. Rueda, J. Haas, Y. Chang, and A.F. Fuller Endometrial cancer in women 40 years old or younger Gynecol Oncol 83 2001 388 393
6. W.H. Gotlieb, M.E. Beiner, B. Shalmon, Y. Korach, Y. Segal, and N. Zmira Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer Obstet Gynecol 102 2003 718 725
7. M. Imai, T. Jobo, R. Sato, M. Kawaguchi, and H. Kuramoto Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations Eur J Gynaecol Oncol 22 2001 217 220
8. T. Kaku, H. Yoshikawa, H. Tsuda, A. Sakamoto, M. Fukunaga, and Y. Kuwabara Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome Cancer Lett 167 2001 39 48
9. Y.B. Kim, C.H. Holschneider, K. Ghosh, R.K. Nieberg, and F.J. Montz Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature Cancer 79 1997 320 327
10. T. Minaguchi, S. Nakagawa, Y. Takazawa, T. Nei, K. Horie, and T. Fujiwara Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium Cancer Lett 248 1 2007 112 122
11. K. Niwa, K. Tagami, Z. Lian, K. Onogi, H. Mori, and T. Tamaya Outcome of fertility-preserving treatment in young women with endometrial carcinomas Brit J Obstet Gynaecol 112 2005 317 320
12. T. Ota, M. Yoshida, M. Kimura, and K. Kinoshita Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger Int J Gynecol Cancer 15 2005 657 662
13. T.C. Randall, and R.J. Kurman Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 Obstet Gynecol 90 1997 434 440
14. M. Saegusa, and I. Okayasu Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis Cancer 83 1998 111 121
15. K. Ushijima, H. Yahata, H. Yoshikawa, I. Konishi, T. Yasugi, and T. Saito Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women J Clin Oncol 25 2007 2798 2803
16. C.B. Wang, C.J. Wang, H.J. Huang, S. Hsueh, H.H. Chou, and Y.K. Soong Fertility-preserving treatment in young patients with endometrial adenocarcinoma Cancer 94 2002 2192 2198
17. D.T. Wheeler, R.E. Bristow, and R.J. Kurman Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins Am J Surg Pathol 31 2007 988 998
18. K. Yamazawa, M. Hirai, A. Fujito, H. Nishi, F. Terauchi, and H. Ishikura Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer Hum Reprod 22 2007 1953 1958
19. L.C. Horn, U. Schnurrbusch, K. Bilek, B. Hentschel, and J. Einenkel Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment Int J Gynecol Cancer 14 2004 348 353
20. T. Jobo, M. Kawaguchi, M. Imai, and H. Kuramoto Treatment for complex atypical hyperplasia of the endometrium Eur J Gynaecol Oncol 22 2001 365 368
21. M.R. Milam, P.T. Soliman, L.H. Chung, K.M. Schmeler, R.L. Bassett Jr., and R.R. Broaddus Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia Int J Gynecol Cancer 18 2008 146 151
22. S. Wang, J. Pudney, J. Song, G. Mor, P.E. Schwartz, and W. Zheng Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia-precursor of endometrial cancer Gynecol Oncol 88 2003 108 117
23. C.L. Trimble, J. Kauderer, R. Zaino, S. Silverberg, P.C. Lim, and J.J. Burke 2nd Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study Cancer 106 2006 812 819
24. T. Kimura, S. Kamiura, T. Komoto, H. Seino, K. Tenma, and Y. Ohta Clinical over- and under-estimation in patients who underwent hysterectomy for atypical endometrial hyperplasia diagnosed by endometrial biopsy: the predictive value of clinical parameters and diagnostic imaging Eur J Obstet Gynecol Reprod Biol 108 2003 213 216
25. R.J. Kurman, P.F. Kaminski, and H.J. Norris The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients Cancer 56 1985 403 412
26. L. Deligdisch Hormonal pathology of the endometrium Mod Pathol 13 2000 285 294
27. G.L. Mutter Diagnosis of premalignant endometrial disease J Clin Pathol 55 2002 326 331
28. L. Deligdisch Effects of hormone therapy on the endometrium Mod Pathol 6 1993 94 106
29. K.J. Rothman, S. Greenland, and T.L. Lash Modern epidemiology 3 rd Edtion 2008 Wolters Kluwer: Lippincott Willaims & Wilkins Philadelphia 269
30. L. Breiman, J.H. Friedman, R.A. Olshen, and C.J. Stone Classification and regression trees 1984 Wadsworth Monterey, CA
31. J.A. Koziol, J.Y. Zhang, C.A. Casiano, X.X. Peng, F.D. Shi, and A.C. Feng Recursive partitioning as an approach to selection of immune markers for tumor diagnosis Clin Cancer Res 9 2003 5120 5126
32. H. Zhang, and B. Singer Recursive partitioning in the health sciences 1999 Springer New York
33. E.J. Atkinson, and T.M. Therneau An introduction to recursive partitioning usisng the RPART routines Technical Report, Mayo Clinic Section of Biostatistics 2000
34. D. Clayton, and M. Hills Statistical models in epidemiology 1993 Oxford Univeristy Press New York 122 132
35. Gynecologic Oncology Group Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia (GOG 224) http:// clinicaltrials.gov/ct/show/NCT00503581
36. Korean Gynecologic Oncology Group Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: Multicenter Study: Korean Gynecologic Oncology Group Study (KGOG2006) http://clinicaltrials.gov/ct2/show/ NCT01234818
37. M.D. Anderson Cancer Center. Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC) (PI: Diane Bodurka, MD) http://clinicaltrials.gov/show/ NCT00788671
38. New York University School of Medicine. Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate (PI: Stephanie Blank, MD) http://clinicaltrials.gov/show/NCT00483327